Literature DB >> 966154

Assay of sulfonylureas in human plasma by high-performance liquid chromatography.

S Sved, I J McGilveray, N Beaudoin.   

Abstract

A sensitive and specific high-performance liquid chromatographic procedure for the determination of chlorpropamide or tolbutamide in plasma in the presence of their metabolites is described. The ether extract of acidified plasma is redissolved in the mobile phase, 17% acetonitrile in 0.05 M aqueous ammonium formate, and chromatographed on a reverse-phase column on a high-performance liquid chromatograph fitted with a UV absorbance detector. Quantitation of plasma samples containing less than 0.5 mug/ml of chlorpropamide and 5 mug/ml of tolbutamide is reported, using these drugs as mutual internal standards. The retention times of the metabolites are such that they do not interfere in the procedure. The assay method was tested in a human volunteer with both drugs and found suitable for single-dose pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 966154     DOI: 10.1002/jps.2600650924

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  An alternative approach for assessment of rate of absorption in bioequivalence studies.

Authors:  M L Chen
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

2.  Insulinomas.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-21

3.  The management of the hypoglycemic patient.

Authors:  T Kennedy
Journal:  World J Surg       Date:  1982-11       Impact factor: 3.352

4.  Characterization of the chlorpropamide-alcohol-flush in patients with type 1 and type 2 diabetes.

Authors:  A E Pontiroli; A De Pasqua; R Colombo; C Ricordi; G Pozza
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun

5.  Neurological aspects of insulinomas.

Authors:  P Daggett; J Nabarro
Journal:  Postgrad Med J       Date:  1984-09       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.